These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36522238)

  • 21. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
    Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
    Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nature of chronic rejection after lung transplantation: a murine orthotopic lung transplant study.
    Heigl T; Kaes J; Aelbrecht C; Serré J; Yamada Y; Geudens V; Van Herck A; Vanstapel A; Sacreas A; Ordies S; Frick A; Saez Gimenez B; Van Slambrouck J; Beeckmans H; Acet Oztürk NA; Orlitova M; Vaneylen A; Claes S; Schols D; Vande Velde G; Schupp J; Kaminski N; Boesch M; Korf H; van der Merwe S; Dupont L; Vanoirbeek J; Godinas L; Van Raemdonck DE; Janssens W; Gayan-Ramirez G; Ceulemans LJ; McDonough JE; Verbeken EK; Vos R; Vanaudenaerde BM
    Front Immunol; 2024; 15():1369536. PubMed ID: 38736881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Profiling in Lung Biopsies of Human Pulmonary Allografts to Predict Chronic Lung Allograft Dysfunction.
    Jonigk D; Izykowski N; Rische J; Braubach P; Kühnel M; Warnecke G; Lippmann T; Kreipe H; Haverich A; Welte T; Gottlieb J; Laenger F
    Am J Pathol; 2015 Dec; 185(12):3178-88. PubMed ID: 26476349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice.
    Watanabe T; Martinu T; Chruscinski A; Boonstra K; Joe B; Horie M; Guan Z; Bei KF; Hwang DM; Liu M; Keshavjee S; Juvet SC
    Am J Transplant; 2019 Dec; 19(12):3377-3389. PubMed ID: 31365766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival.
    Combs MP; Xia M; Wheeler DS; Belloli EA; Walker NM; Braeuer RR; Lyu DM; Murray S; Lama VN
    J Heart Lung Transplant; 2020 Aug; 39(8):815-823. PubMed ID: 32360292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Rejection and Chronic Lung Allograft Dysfunction: Obstructive and Restrictive Allograft Dysfunction.
    Beeckmans H; Bos S; Vos R; Glanville AR
    Clin Chest Med; 2023 Mar; 44(1):137-157. PubMed ID: 36774160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type-1 immunity and endogenous immune regulators predominate in the airway transcriptome during chronic lung allograft dysfunction.
    Iasella CJ; Hoji A; Popescu I; Wei J; Snyder ME; Zhang Y; Xu W; Iouchmanov V; Koshy R; Brown M; Fung M; Langelier C; Lendermon EA; Dugger D; Shah R; Lee J; Johnson B; Golden J; Leard LE; Ellen Kleinhenz M; Kilaru S; Hays SR; Singer JP; Sanchez PG; Morrell MR; Pilewski JM; Greenland JR; Chen K; McDyer JF
    Am J Transplant; 2021 Jun; 21(6):2145-2160. PubMed ID: 33078555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
    Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
    Transpl Int; 2021; 35():10184. PubMed ID: 35185369
    [No Abstract]   [Full Text] [Related]  

  • 29. Ferret Lung Transplantation Models Differential Lymphoid Aggregate Morphology Between Restrictive and Obstructive Forms of Chronic Lung Allograft Dysfunction.
    Lynch TJ; Ahlers BA; Swatek AM; Ievlev V; Pai AC; Brooks L; Tang Y; Evans IA; Meyerholz DK; Engelhardt JF; Parekh KR
    Transplantation; 2022 Oct; 106(10):1974-1989. PubMed ID: 35442232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
    Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
    Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PLK1 Inhibition alleviates transplant-associated obliterative bronchiolitis by suppressing myofibroblast differentiation.
    Yu J; Xu H; Cui J; Chen S; Zhang H; Zou Y; Zhao J; Le S; Jiang L; Chen Z; Liu H; Zhang D; Xia J; Wu J
    Aging (Albany NY); 2020 Jun; 12(12):11636-11652. PubMed ID: 32541091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative chest CT for subtyping chronic lung allograft dysfunction and its association with survival.
    Horie M; Salazar P; Saito T; Binnie M; Brock K; Yasufuku K; Azad S; Keshavjee S; Martinu T; Paul N
    Clin Transplant; 2018 May; 32(5):e13233. PubMed ID: 29637624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
    von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update in Chronic Lung Allograft Dysfunction.
    Shah RJ; Diamond JM
    Clin Chest Med; 2017 Dec; 38(4):677-692. PubMed ID: 29128018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction.
    Mineura K; Tanaka S; Goda Y; Terada Y; Yoshizawa A; Umemura K; Sato A; Yamada Y; Yutaka Y; Ohsumi A; Nakajima D; Hamaji M; Mennju T; Kreisel D; Date H
    Am J Transplant; 2024 Jun; 24(6):944-953. PubMed ID: 38403187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal lung function measurements in single lung transplant recipients with chronic lung allograft dysfunction.
    Leuschner G; Lauseker M; Howanietz AS; Milger K; Veit T; Munker D; Schneider C; Weig T; Michel S; Barton J; Meiser B; Dinkel J; Neurohr C; Behr J; Kneidinger N
    J Heart Lung Transplant; 2020 Nov; 39(11):1270-1278. PubMed ID: 32917480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor Batf3 inhibits murine lung allograft rejection and airway fibrosis.
    Watanabe T; Lam C; Oliver J; Oishi H; Teskey G; Beber S; Boonstra K; Mauricio Umaña J; Buhari H; Joe B; Guan Z; Horie M; Keshavjee S; Martinu T; Juvet SC
    Mucosal Immunol; 2023 Apr; 16(2):104-120. PubMed ID: 36842540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of stromal cell Thy-1 plays a critical role in lipopolysaccharide induced chronic lung allograft dysfunction.
    Hata A; Guo Y; Miller AE; Hata M; Mei Z; Manafi A; Li D; Banerjee A; Lazear E; Lau C; Gelman AE; Kreisel D; Yoshino I; Wilkes D; Barker TH; Krupnick AS
    J Heart Lung Transplant; 2022 Aug; 41(8):1044-1054. PubMed ID: 35691796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
    Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
    Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.